Rationale and study design of a three-period, 58-week trial of ferric citrate as a phosphate binder in patients with ESRD on dialysis-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Rationale and study design of a three-period, 58-week trial of ferric citrate as a phosphate binder in patients with ESRD on dialysis

Published:2012-06-15 Issue:1 Volume:17 Page:67-74
ISSN:1492-7535
Container-title:Hemodialysis International
language:en
Short-container-title:Hemodial Int

Author:

Umanath Kausik¹,Sika Mohammed²,Niecestro Robert³,Connelly Carolyn³,Schulman Gerald²,Koury Mark J.⁴,Lewis Julia B.²,Dwyer Jamie P.²,

Affiliation:

1. Division of Nephrology and Hypertension; Henry Ford Hospital; Detroit; MI; USA

2. Division of Nephrology and Hypertension; Vanderbilt University Medical Center; Nashville; TN; USA

3. Keryx Biopharmaceuticals, Inc; New York; NY; USA

4. Division of Hematology and Oncology; Vanderbilt University Medical Center; Nashville; TN; USA

Publisher

Wiley

Subject

Nephrology,Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1542-4758.2012.00711.x/fullpdf

Reference28 articles.

1. Pathogenesis of secondary hyperparathyroidism;Slatopolsky;Kidney Int Suppl,1999

2. Mineral metabolism, mortality, and morbidity in maintenance hemodialysis;Block;J Am Soc Nephrol,2004

3. Accumulation of metals and minerals from phosphate binders;Molony;Blood Purif,2005

4. The effect of a high intake of calcium and phosphate in normal subjects and patients with chronic renal failure;Clarkson;Clin Sci,1970

5. Net intestinal absorption of calcium in patients with chronic renal failure;Clarkson;Kidney Int,1973

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Phosphate binders for preventing and treating chronic kidney disease-mineral and bone disorder (CKD-MBD);Cochrane Database of Systematic Reviews;2018-08-22

2. The safety of achieved iron stores and their effect on IV iron and ESA use: post-hoc results from a randomized trial of ferric citrate as a phosphate binder in dialysis;Clinical Nephrology;2017-03-01

3. We Give Too Much Intravenous Iron;Seminars in Dialysis;2016-05-07

4. Iron-based phosphate binders – a new element in management of hyperphosphatemia;Expert Opinion on Drug Metabolism & Toxicology;2015-11-16

5. The Phosphate Binder Ferric Citrate and Mineral Metabolism and Inflammatory Markers in Maintenance Dialysis Patients: Results From Prespecified Analyses of a Randomized Clinical Trial;American Journal of Kidney Diseases;2015-09

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3